Medicaid beneficiaries are encouraged to update their information with Medicaid to ensure continued coverage.
Site Search
The Cystic Fibrosis Foundation is providing additional funds to TB Alliance to advance the development of a compound that could be used to treat infections caused by nontuberculous mycobacteria.
More than 60 teens from across the country — almost half of whom live with cystic fibrosis — advocated for support of the PASTEUR Act.
Melanie Lawrence, an adult with cystic fibrosis, was selected to testify before a Senate Health, Education, Labor and Pensions subcommittee regarding the impact of antimicrobial resistance on patients who face heightened risk of infections, like those with CF.
To date, the CF Foundation has funded more than $1 million to programs created by and for the CF community.
ViaNautis’ non-viral delivery mechanism, polyNaut®, aims to improve delivery of genetic therapies to the cells of people with CF.
Funding will support clinical trials for therapy that could help improve digestion in people with CF
Foundation to fund up to $110 million for collaboration to accelerate the development of genetic therapies for CF
The treatment has the potential to prevent Aspergillus fungal infections in people who have had a lung transplant.
Addressing variability in newborn screening can prevent missed diagnoses and delays in early care intervention.